Related references
Note: Only part of the references are listed.MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis
Harinath Bahudhanapati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Emerging roles for the relaxin/RXFP1 system in cancer therapy
Thatchawan Thanasupawat et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Serum relaxin level predicts recurrence of atrial fibrillation after radiofrequency catheter ablation
Xiang Qu et al.
HEART AND VESSELS (2019)
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
Elena M. Kaftanovskaya et al.
FASEB JOURNAL (2019)
AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
Bryna S. M. Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Cardioprotective actions of relaxin
Brian Martin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Understanding relaxin signalling at the cellular level
Adam L. Valkovic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis
Beata Nagorniewicz et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Human Relaxin-2 Fusion Protein Treatment Prevents and Reverses Isoproterenol-Induced Hypertrophy and Fibrosis in Mouse Heart
Junhui Sun et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis
Bradley L. Hoare et al.
ISCIENCE (2019)
Relaxin induces up-regulation of ADAM10 metalloprotease in RXFP1-expressing cells by PI3K/AKT signaling
Giulia Boccalini et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
The relaxin receptor as a therapeutic target - perspectives from evolution Cheek for updates and drug targeting
Ross A. D. Bathgate et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases
Maggie Lam et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Heart Disease and Relaxin: New Actions for an Old Hormone
Teja Devarakonda et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
Hooi Hooi Ng et al.
FRONTIERS IN PHARMACOLOGY (2018)
Major lung complications of systemic sclerosis
Christopher P. Denton et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Anti-fibrotic actions of relaxin
C. S. Samuel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The actions of relaxin on the human cardiovascular system
Mohsin Sarwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload
Mariana Pintalhao et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis
Andrew McBride et al.
SCIENTIFIC REPORTS (2017)
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
Martina Kocan et al.
SCIENTIFIC REPORTS (2017)
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial
Victoria K. Snowdon et al.
PLOS MEDICINE (2017)
Novel Anti-fibrotic Therapies
Benita L. McVicker et al.
FRONTIERS IN PHARMACOLOGY (2017)
Anti-fibrotic Potential of AT2 Receptor Agonists
Yan Wang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290
Elena M. Kaftanovskaya et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
The angiotensin type 2 receptor and the kidney
Antonio A. B. Peluso et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis Implications for Relaxin-based Therapies
Jiangning Tan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Optogenetic user's guide to Opto-GPCRs
Sonja Kleinlogel
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels
Brian L. Henry et al.
HEART RHYTHM (2016)
Relaxin Level in Patients With Atrial Fibrillation and Association with Heart Failure Occurrence: A STROBE Compliant Article
Hao Zhou et al.
MEDICINE (2016)
SINGLE-CHAIN DERIVATIVE OF THE RELAXIN HORMONE IS A FUNCTIONALLY SELECTIVE AGONIST OF THE G PROTEIN-COUPLED RECEPTOR,RXFP1
M. A. Hossain et al.
JOURNAL OF PEPTIDE SCIENCE (2016)
The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1
Ashish Sethi et al.
NATURE COMMUNICATIONS (2016)
A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1
Mohammed Akhter Hossain et al.
CHEMICAL SCIENCE (2016)
In a class of their own-RXFP1 and RXFP2 are unique members of the LGR family
Emma J. Petrie et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Role of the extracellular and intracellular loops of follicle-stimulating hormone receptor in its function
Antara A. Banerjee et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1-4, the Receptors for Relaxin Family Peptides
Michelle L. Halls et al.
PHARMACOLOGICAL REVIEWS (2015)
The relaxin family peptide receptors and their ligands: New developments and paradigms in the evolution from jawless fish to mammals
Sergey Yegorov et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2014)
Relaxin Modulates Human and Rat Hepatic Myofibroblast Function and Ameliorates Portal Hypertension In Vivo
Jonathan A. Fallowfield et al.
HEPATOLOGY (2014)
Investigation of Interactions at the Extracellular Loops of the Relaxin Family Peptide Receptor 1 (RXFP1)
Natalie A. Diepenhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
Bryna S. Man Chow et al.
KIDNEY INTERNATIONAL (2014)
New targets for renal interstitial fibrosis: relaxin family peptide receptor 1-angiotensin type 2 receptor heterodimers
Jennifer M. Sasser
KIDNEY INTERNATIONAL (2014)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease
Jennifer M. Sasser
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts
Ashish Parikh et al.
CIRCULATION RESEARCH (2013)
Lgr proteins in epithelial stem cell biology
Nick Barker et al.
DEVELOPMENT (2013)
Molecular signatures of G-protein-coupled receptors
A. J. Venkatakrishnan et al.
NATURE (2013)
RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS
R. A. D. Bathgate et al.
PHYSIOLOGICAL REVIEWS (2013)
Lifting the lid on GPCRs: the role of extracellular loops
M. Wheatley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
Bryna Suet Man Chow et al.
PLOS ONE (2012)
Expression of RXFP1 in skin of scleroderma patients and control subjects
N. Giordano et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
Andrew S. Dore et al.
STRUCTURE (2011)
Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis
Ruth L. Vinall et al.
Hormones & Cancer (2011)
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis
Shu Feng et al.
ENDOCRINE-RELATED CANCER (2010)
Prevention of Bleomycin-Induced Pulmonary Fibrosis by a Novel Antifibrotic Peptide with Relaxin-Like Activity
Alessandro Pini et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Cardiovascular effects of relaxin: from basic science to clinical therapy
Xiao-Jun Du et al.
NATURE REVIEWS CARDIOLOGY (2010)
Dimerization and Negative Cooperativity in the Relaxin Family Peptide Receptors
Angela Manegold Svendsen et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Mechanisms of Relaxin Receptor (LGR7/RXFP1) Expression and Function
Andras Kern et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Cutaneous Involvement A Randomized, Double-Blind, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2009)
Circulating levels of relaxin and its relation to cardiovascular function in patients with hypertension
Omer Gedikli et al.
BLOOD PRESSURE (2009)
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
Ishanee Mookerjee et al.
FASEB JOURNAL (2009)
Relaxin and its role in the development and treatment of fibrosis
Robert G. Bennett
TRANSLATIONAL RESEARCH (2009)
Relaxin family peptide receptors - from orphans to therapeutic targets
Emma T. van der Westhuizen et al.
DRUG DISCOVERY TODAY (2008)
Cloning, expression, and functional characterization of relaxin receptor (leucine-rich repeat-containing g protein-coupled receptor 7) splice variants from human fetal membranes
Andras Kern et al.
ENDOCRINOLOGY (2008)
Cooperative binding of insulin-like peptide 3 to a dimeric relaxin family peptide receptor 2
Angela Manegold Svendsen et al.
ENDOCRINOLOGY (2008)
Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1
Angela Manegold Svendsen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis
R. A. D. Bathgate et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Crystal structure of opsin in its G-protein-interacting conformation
Patrick Scheerer et al.
NATURE (2008)
AT2 receptors: Functional relevance in cardiovascular disease
Emma S. Jones et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Relaxin promotes prostate cancer progression
Shu Feng et al.
CLINICAL CANCER RESEARCH (2007)
The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation
Emma J. Hopkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis
Tim D. Hewitson et al.
ENDOCRINOLOGY (2007)
Relaxin Family Peptide Receptors - former orphans reunite with their parent ligands to activate multiple signalling pathways
M. L. Halls et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules
Daniel J. Scott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Relaxin enhances the oncogenic potential of human thyroid carcinoma cells
Sabine Hombach-Klonisch et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms
Michelle L. Halls et al.
MOLECULAR PHARMACOLOGY (2006)
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Chrishan S. Samuel
CLINICAL MEDICINE & RESEARCH (2005)
The relaxin gene knockout mouse: A model of progressive scleroderma
CS Samuel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Effect of relaxin on myocardial ischemia injury induced by isoproterenol
J Zhang et al.
PEPTIDES (2005)
Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity
M Muda et al.
MOLECULAR HUMAN REPRODUCTION (2005)
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
MHJ Heeg et al.
KIDNEY INTERNATIONAL (2005)
Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8)
ML Halls et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Is the pregnancy hormone relaxin an important player in human heart failure?
M Kupari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Evolution of the relaxin-like peptide family
TN Wilkinson et al.
BMC EVOLUTIONARY BIOLOGY (2005)
Relaxin regulation of endometrial structure and function in the rhesus monkey
LT Goldsmith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Genetic targeting of relaxin and insulin-like factor 3 receptors in mice
AA Kamat et al.
ENDOCRINOLOGY (2004)
Relaxin-1-deficient mice develop an age-related progression of renal fibrosis
CS Samuel et al.
KIDNEY INTERNATIONAL (2004)
Relaxin is an independent risk factor predicting death in male patients with end-stage kidney disease
B Hocher et al.
CIRCULATION (2004)
Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo
GA McDonald et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases
C Binder et al.
MOLECULAR HUMAN REPRODUCTION (2002)
INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent
J Kumagai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of orphan receptors by the hormone relaxin
SY Hsu et al.
SCIENCE (2002)
Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells
P Failli et al.
FASEB JOURNAL (2001)
Folding determinants of LDL receptor type A modules
V Koduri et al.
BIOCHEMISTRY (2001)
Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo
EJ Williams et al.
GUT (2001)
Crystal structure of rhodopsin: A G protein-coupled receptor
K Palczewski et al.
SCIENCE (2000)
Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial
JR Seibold et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
